Skip to main content
. 2014 Dec 10;14:206. doi: 10.1186/s12876-014-0206-x

Table 1.

Pooled analysis of studies exploring the role of TLR4 Asp299Gly in CD

Study Cases (Events/Total) Controls (Events/Total) Odds ratio 95% CI P value
Arnott et al. 2004 [ 31 ] 50/468 33/378 1,25 0,79 to 1,98
Franchimont et al. 2004 [ 32 ] (1) 73/668 14/278 2,31 1,28 to 4,17
Franchimont et al. 2004 [ 32 ] (2) 26/226 14/278 2,45 1,25 to 4,81
Torok et al. 2004 [ 33 ] 14/204 12/290 1,70 0,77 to 3,77
Braat et al. 2005 [ 34 ] 68/822 13/274 1,81 0,98 to 3,33
Brand et al. 2005 [ 22 ] 29/408 15/398 1,95 1,03 to 3,70
Lakatos et al. 2005 [ 35 ] 104/1054 48/400 0,80 0,56 to 1,15
Gazouli et al. 2005 [ 36 ] 19/240 6/200 2,78 1,09 to 7,10
Oostenbrug et al. 2005 [ 37 ] 53/786 27/592 1,51 0,94 to 2,43
Ouburg et al. 2005 [ 38 ] 23/224 18/340 2,04 1,08 to 3,88
Fries et al. 2005 [ 39 ] (1) 2/46 2/118 2,63 0,36 to 19,29
Fries et al. 2005 [ 39 ] (2) 10/120 2/118 5,27 1,13 to 24,60
Zouiten-Mekki et al. 2009 [ 40 ] 12/180 9/160 1,19 0,49 to 2,92
Hong et al. 2007 [ 41 ] 26/364 32/376 0,82 0,48 to 1,42
Baumgart et al. 2007 [ 21 ] (1) 6/288 16/404 0,51 0,20 to 1,33
Baumgart et al. 2007 [ 21 ] (2) 28/482 49/806 0,95 0,59 to 1,54
Browning et al. 2007 [ 42 ] 50/778 44/832 1,23 0,81 to 1,86
De Ridder et al. 2007 [ 23 ] (1) 11/144 20/488 1,93 0,91 to 4,14
De Ridder et al. 2007 [ 23 ] (2) 63/756 20/488 2,12 1,27 to 3,56
Riis et al. 2007 [ 43 ] 32/422 152/1236 0,58 0,39 to 0,87
Hume et al. 2008 [ 44 ] 87/1238 36/720 1,43 0,96 to 2,14
Rigoli et al. 2008 [ 45 ] 10/266 8/206 0,96 0,38 to 2,49
Manolakis et al. 2013 [ 46 ] 20/326 33/548 1,02 0,58 to 1,81
Current study 2014 9/166 10/224 1,22 0,49 to 3,09
Total (fixed effects) 825/10676 633/10152 1,26 1,13 to 1,42 0.0001
Total (random effects) 825/10676 633/10152 1,35 1,12 to 1,64
HHS Vulnerability Disclosure